For achieving the ambitious project objectives, a multidisciplinary Consortium with an internationally renowned background is the key for success. The ADMAIORA Consortium consists of:
- two leading universities with high international reputation on bioengineering and biorobotics (The BioRobotics Institute of Scuola Superiore Sant’Anna – the Coordinator) and on the development of carbon-based nanomaterials (Bar-Ilan University);
- one scientific research hospital, which is a European leader in osteoarthritis treatment by autologous stem cells and in the biological and preclinical validation of novel technologies for orthopaedic applications (Istituto Ortopedico Rizzoli);
- five strong motivated SME companies with long and consolidated traditions in the field of biomaterials for cartilage regeneration (Regentis), ultrasound technologies for diagnosis and treatment (Image Guided Therapy), synthesis and functionalization of nanomaterials, especially piezoelectric ones (PlasmaChem GmbH), development of custom surgical tools for arthroscopy (Vimex) and development of wireless communication, software and IoT technologies (H&D Wireless).
The countries represented in the Consortium are 6 (Italy, Israel, France, Germany, Poland and Sweden). This geographical distribution constitutes a living example of collaboration in the European Research Area, including Israel, which is third country eligible for H2020 funding.